GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Pretax Margin %

IBO (Impact BioMedical) Pretax Margin % : % (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Impact BioMedical's Pre-Tax Income for the three months ended in Sep. 2024 was $4.24 Mil. Impact BioMedical's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Impact BioMedical's pretax margin for the quarter that ended in Sep. 2024 was %.

The historical rank and industry rank for Impact BioMedical's Pretax Margin % or its related term are showing as below:


IBO's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -137.46
* Ranked among companies with meaningful Pretax Margin % only.

Impact BioMedical Pretax Margin % Historical Data

The historical data trend for Impact BioMedical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Pretax Margin % Chart

Impact BioMedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- - -15,752.00 -15,752.00 -

Impact BioMedical Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Impact BioMedical's Pretax Margin %

For the Biotechnology subindustry, Impact BioMedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Impact BioMedical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impact BioMedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Impact BioMedical's Pretax Margin % falls into.


;
;

Impact BioMedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Impact BioMedical's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.407/0
= %

Impact BioMedical's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=4.241/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impact BioMedical  (AMEX:IBO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Impact BioMedical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Impact BioMedical Business Description

Traded in Other Exchanges
N/A
Address
275 Wiregrass Parkway, West Henrietta, NY, USA, 14586
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical Headlines